

PTC Therapeutics plans to acquire Sangamo’s ST-920 Fabry disease program for $111 million upfront, with FDA filing expected in Q4 2026.
You can purchase shares of Invesco S&P SmallCap Health Care ETF (NASDAQ:PSCH) through any online brokerage.
There are no as such competitors for Invesco S&P SmallCap Health Care ETF.
There is no analysis for Invesco S&P SmallCap Health Care ETF to provide a consensus price target.
The stock price for Invesco S&P SmallCap Health Care ETF (NASDAQ: PSCH) is $55.6499 last updated November 2, 2026 at 10:42 AM EST.
There are no upcoming dividends for Invesco S&P SmallCap Health Care ETF.
Invesco S&P SmallCap Health Care ETF does not have any upcoming earnings scheduled.
There is no upcoming split for Invesco S&P SmallCap Health Care ETF.
The fund generally will invest at least 90% of its total assets in the securities of small-capitalization U.S. healthcare companies that comprise the underlying index. These companies are principally engaged in the business of providing...